TMC Life Shareholders Seek Removal Of Director, Wan Nadiah
TMC Life Shareholders Seek Removal Of Director, Wan Nadiah
TMC Life informed Bursa that it received special notices from Sasteria (M) Pte. Ltd. and DYAM Tunku Ismail Ibni Sultan Ibrahim, being shareholders of the company holding in aggregate more than half of the total voting rights to hold an EGM for the removal of the suspended CEO Wan Nadiah.
TMC Life告知布爾薩,它收到了Sasteria(M)私人公司的特別通知。Ltd. 和DyAm Tunku Ismail Ibni Sultan Ibrahim是該公司的股東,共持有爲罷免被停職的首席執行官萬·納迪亞舉行臨時股東大會的總投票權的一半以上。
Wan Nadiah is the Chief Executive Officer of Thomson Hospital and also the director of TMC Life,
萬·納迪亞是湯姆森醫院的首席執行官,也是TMC Life的董事,
There is currently ongoing proceedings between the group and Wan Nadiah including a domestic inquiry over her suspension.
目前,該團體與萬·納迪亞正在進行訴訟,包括對她的停職的國內調查。
On the latest notice, TMC said it will inform the shareholders on date of the Extraordinary General Meeting in due course.
在最新的通知中,TMC表示將在適當的時候將特別股東大會的日期通知股東。
譯文內容由第三人軟體翻譯。